GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Impedimed Ltd (OTCPK:IPDQF) » Definitions » Other Long Term Assets

IPDQF (Impedimed) Other Long Term Assets : $0.00 Mil (As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is Impedimed Other Long Term Assets?

Impedimed's other long-term assets for the quarter that ended in Dec. 2024 was $0.00 Mil.

Impedimed's quarterly other long-term assets increased from Dec. 2023 ($0.00 Mil) to Jun. 2024 ($0.04 Mil) but then stayed the same from Jun. 2024 ($0.04 Mil) to Dec. 2024 ($0.00 Mil).

Impedimed's annual other long-term assets declined from Jun. 2022 ($0.13 Mil) to Jun. 2023 ($0.00 Mil) but then increased from Jun. 2023 ($0.00 Mil) to Jun. 2024 ($0.04 Mil).


Impedimed Other Long Term Assets Historical Data

The historical data trend for Impedimed's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Impedimed Other Long Term Assets Chart

Impedimed Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.13 - 0.04

Impedimed Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 0.04 -

Impedimed Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


Impedimed Business Description

Traded in Other Exchanges
Address
50 Parker Court, Unit 1, Pinkenba, QLD, AUS, 4008
Impedimed Ltd, together with its subsidiaries, operates in the medical devices space. The company is based in Australia and operates globally, and it generates the majority of its revenue in North America. It is engaged in developing, manufacturing, and distributing noninvasive medical devices. The company offers products that are typically used to assess and monitor lymphedema and heart failure, as well as to measure the tissue composition and fluid status of the patients. The company also offers a cloud-based digital platform (branded as SOZO) to manage patient data. The company recognizes revenue from the stand-alone sale of Legacy Devices and Consumables, the Sale of SOZO Devices, and Software Subscription Services.

Impedimed Headlines

From GuruFocus

ImpediMed Ltd Investor Conference Call Transcript

By GuruFocus Research 02-14-2024

Full Year 2022 ImpediMed Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2022 ImpediMed Ltd Activities Report Call Transcript

By GuruFocus Research 02-14-2024

ImpediMed Ltd Ordinary Shareholders Meeting Transcript

By GuruFocus Research 09-14-2024

Q4 2020 ImpediMed Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

ImpediMed Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024

Q4 2023 ImpediMed Ltd Cashflow Reports Call Transcript

By GuruFocus Research 02-14-2024

Q3 2020 ImpediMed Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

ImpediMed Ltd Corporate Call Transcript

By GuruFocus Research 02-14-2024